Skip to content

SUIG SUIG Deferred Tax Assets Tax Credit Carryforwards Research Developments And Foreign

Deferred Tax Assets Tax Credit Carryforwards Research Developments And Foreign at other companies

HRO
HarrowHROW
$78K-86.5%
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
$98K
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$4.96M+96.0%
Mondelez International logo
Mondelez InternationalMDLZ
$773M+5.0%
Raytheon Technologies logo
Raytheon TechnologiesRTX
$963M+20.4%
Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$5.87M+23.7%

Other financials

Income statement

See full
Revenue$593.9K-23.7%
Operating income-$60.5M-10,890%
Net income-$70.9M-15,805%
EPS (diluted)-$0.88-1,357%

Balance sheet

See full
Cash & equivalents$5.0M+186%
Total debt$3.7K-66.3%
Total equity$100.8M+415%
Total assets$118.7M+498%

Cash flow

See full
Operating cash flow-$1.8M+50.6%

Valuation

See full
Market cap$93.84M-82.6%
P/S25.3×

Profitability

See full
Operating margin-8,777.7%
Net margin-9,073.3%

Returns & leverage

See full
Return on equity-560%
Debt / equity0.0×
Current ratio0.8×

Where this comes from

Reported directly by SUIG in its filing.

Tagged under the XBRL concept suig:DeferredTaxAssetsTaxCreditCarryforwardsResearchDevelopmentsAndForeign.

The official record: SUIG’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about SUIG's deferred tax assets tax credit carryforwards research developments and foreign.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SUIG's deferred tax assets tax credit carryforwards research developments and foreign?
SUIG (SUIG) reported deferred tax assets tax credit carryforwards research developments and foreign of $40.82K in Q4 2025.
What does deferred tax assets tax credit carryforwards research developments and foreign mean?
The value of tax credits related to research and development activities that can be carried forward to offset future tax liabilities. This metric reflects the company's investment in innovation and its ability to utilize tax incentives to improve cash flow. It serves as a potential future reduction in the company's tax burden.